Comparison between Ganga Pharmaceuticals IPO and Navigant Corporate Advisors IPO.
Ganga Pharmaceuticals IPO is a SME Fixed Price IPO proposed to list at BSE SME while Navigant Corporate Advisors IPO is a SME Fixed Price proposed to list at BSE SME.
| Ganga Pharmaceuticals IPO | Navigant Corporate Advisors IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | BSE SME | BSE SME |
| Lead Managers | First Overseas Capital Ltd. | First Overseas Capital Ltd. |
| Registrar | Kfin Technologies Ltd. | Kfin Technologies Ltd. |
| Market Maker | Alacrity Securities Ltd. | Naysaa Securities Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Ganga Pharmaceuticals IPO is up to ₹1.54 Cr whereas the issue size of the Navigant Corporate Advisors IPO is up to ₹1.12 Cr. The final issue price of Ganga Pharmaceuticals IPO is ₹15.00 per share and of Navigant Corporate Advisors IPO is ₹14.00 per share.
| Ganga Pharmaceuticals IPO | Navigant Corporate Advisors IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹15.00 per share | ₹14.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 8000 shares | 10000 shares |
| Fresh Issue Size | 10,24,000 shares | 0 shares |
| Fresh Issue Size (Amount) | up to ₹1.54 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 0 shares | 8,00,000 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹1.12 Cr |
| Issue Size Total | 10,24,000 shares | 8,00,000 shares |
| Issue Size Total (Amount) | up to ₹1.54 Cr | up to ₹1.12 Cr |
Ganga Pharmaceuticals IPO opens on Jan 29, 2016, while Navigant Corporate Advisors IPO opens on Nov 30, 2015. The closing date of Ganga Pharmaceuticals IPO and Navigant Corporate Advisors IPO is Feb 09, 2016, and Dec 07, 2015, respectively.
| Ganga Pharmaceuticals IPO | Navigant Corporate Advisors IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Jan 29, 2016 | Nov 30, 2015 |
| Issue Close | Feb 09, 2016 | Dec 07, 2015 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | Feb 22, 2016 | Dec 18, 2015 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Ganga Pharmaceuticals IPO P/E ratio is , as compared to Navigant Corporate Advisors IPO P/E ratio of .
| Ganga Pharmaceuticals IPO | Navigant Corporate Advisors IPO | |
|---|---|---|
| Financials | ||
| Promoter Shareholding (Pre-Issue) | 91.05 | 100 |
| Promoter Shareholding (Post-Issue) | 68.09 | 73.04 |
| P/E Ratio | ||
| Market Cap | ||
| ROE | ||
| ROCE | ||
| Debt/Equity | ||
| EPS | ||
| RoNW | 1.27% | 19.8% |
In the Ganga Pharmaceuticals IPO Retail Individual Investors (RII) are offered 5,12,000 shares while in Navigant Corporate Advisors IPO retail investors are offered 5,12,000 shares. Qualified Institutional Buyers (QIB) are offered in Ganga Pharmaceuticals IPO and in Navigant Corporate Advisors IPO.
| Ganga Pharmaceuticals IPO | Navigant Corporate Advisors IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | 0 shares | 50,000 shares |
| QIB | ||
| NII | 5,12,000 shares | 4,00,000 shares |
| RII | 5,12,000 shares | 4,00,000 shares |
| Employee | ||
| Others | ||
| Total | 10,24,000 shares | 8,00,000 shares |
Ganga Pharmaceuticals IPO subscribed in total, whereas Navigant Corporate Advisors IPO subscribed .
| Ganga Pharmaceuticals IPO | Navigant Corporate Advisors IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | ||
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | ||
| Employee (times) | ||
| Other (times) | ||
| Total (times) |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
